Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis

por Torres, L., Klingberg, E., Nurkkala, M., Carlsten, H., Forsblad-d’Elia, H.
Publicado 2018

Factors associated with changes in volumetric bone mineral density and cortical area in men with ankylosing spondylitis: a 5-year prospective study using HRpQCT.

por Deminger, A., Klingberg, E., Lorentzon, M., Hedberg, M., Carlsten, H., Jacobsson, L.T.H., Forsblad-d’Elia, H.
Publicado 2021

Concomitant Ro/SSA and La/SSB antibodies are biomarkers for the risk of venous thromboembolism and cerebral infarction in primary Sjögren's syndrome

por Mofors, J., Holmqvist, M., Westermark, L., Björk, A., Kvarnström, M., Forsblad‐d'Elia, H., Magnusson Bucher, S., Eriksson, P., Theander, E., Mandl, T., Wahren‐Herlenius, M., Nordmark, G.
Publicado 2019

Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity

por Sternes, P. R., Brett, L., Phipps, J., Ciccia, F., Kenna, T., de Guzman, E., Zimmermann, K., Morrison, M., Holtmann, G., Klingberg, E., Mauro, D., McIvor, C., Forsblad-d’Elia, H., Brown, M. A.
Publicado 2022